Urology & Nephrology Urology & Nephrology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 12.

Mayo Clinic Minute: Hepatitis C Epidemic
Hepatitis C is a worldwide epidemic. Mayo Clinic experts estimate that nearly one-third of the globe's population has been or is infected with the hepatitis C virus. Most people don't know they have the infection because it doesn't cause symptoms until liver damage shows up decades later ⎯ often during routine medical tests. Until recently, the hepatitis [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 16, 2016 Category: Databases & Libraries Source Type: news

Complication Rates Low for Incontinence Sling ProceduresComplication Rates Low for Incontinence Sling Procedures
Despite the high number of litigations, the complication rates for incontinence sling procedures in women are low, but does the surgical specialty of the treating physician alter outcomes? Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2016 Category: Consumer Health News Tags: Urology News Source Type: news

Small Varicoceles Can Make a Big Difference in Sperm QualitySmall Varicoceles Can Make a Big Difference in Sperm Quality
More than half of all enlarged veins in the scrotum are associated with a significant reduction in sperm concentration and quality, new research shows. Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 15, 2016 Category: Urology & Nephrology Tags: Urology News Source Type: news

Cuba Has Made At Least 3 Major Medical Innovations That We Need
By most measures, the United States' business-friendly environment has proven to be fertile for medical innovation. Compared to other countries, America has filed the most patents in the life sciences, is conducting most of the world's clinical trials and has published the most biomedical research. That's what makes the medical prominence of Cuba all the more surprising to those who view a free market as an essential driver of scientific discovery. Cuba is very poor, and yet the country has some of the healthiest, most long-lived residents in the world -- as well as a medical invention or two that could run circl...
Source: Science - The Huffington Post - March 15, 2016 Category: Science Source Type: news

Scientists identify molecular markers of kidney transplant rejection
Genome-wide molecular profiling of kidney biopsies may be a key to catching organ rejection before it's too late, new research demonstrates. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 15, 2016 Category: Science Source Type: news

Reduced immunosuppression drug dose may be best for kidney transplant outcomes, study suggests
Four immunosuppression strategies have been investigated by researchers who have found that many patients might benefit from a lower-than-standard dose of calcineurin inhibitors. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 15, 2016 Category: Science Source Type: news

GI Dynamics to press on despite missed trial endpoints
GI Dynamics (ASX:GID) said today that it still plans to pursue FDA approval for its EndoBarrier weight loss device, despite missing safety and efficacy endpoints in a pivotal U.S. trial of the gut liner. Lexington, Mass.-based GI Dynamics shut down the trial last July after the FDA ordered it to cease enrolling patients due to a higher-than-expected rate of hepatic abscess. The EndoBarrier is a plastic sleeve designed to promote weight loss and relieve the symptoms of diabetes by slowing the uptake of nutrients from food. There were 7 cases of hepatic abscess in the 325-patient trial, for an incidence rate of roughly 3.5%...
Source: Mass Device - March 15, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Food & Drug Administration (FDA) Weight loss GI Dynamics Source Type: news

Patients Needed for Research Project
A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients. Your participation in this research project can help ensure that the company’s website and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way. Flince Research + Design, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf.   The research proje...
Source: Kidney Cancer Association - March 15, 2016 Category: Urology & Nephrology Source Type: news

Largest genomic study on kidney cancer brings hope for more effective treatments
A comprehensive molecular analysis of 894 primary renal cell carcinomas resulted in nine subtypes defined by systematic analysis of five genomic data platforms. Each major histologic types represent substantial molecular diversity.03/15/2016 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - March 15, 2016 Category: Urology & Nephrology Source Type: news

Study suggests reduced immunosuppression drug dose may be best for kidney transplant outcomes
(University of Pennsylvania School of Medicine) Researchers from the Perelman School of Medicine at the University of Pennsylvania, in partnership with ECRI Institute under the ECRI Institute-Penn Medicine Evidence-based Practice Center contract, investigated four immunosuppression strategies and found that many patients might benefit from a lower-than-standard dose of CNIs. Their findings are detailed in a study published this week in the American Journal of Transplantation, with additional research included online in an extended Agency for Healthcare Research and Quality report. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2016 Category: Global & Universal Source Type: news

Takeda, Frazier Healthcare form new company to develop urology and gynaecology therapeutics
Takeda Pharmaceutical and Frazier Healthcare Partners have set up a new biopharmaceutical company to develop new therapeutics in urology and gynaecology. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 15, 2016 Category: Pharmaceuticals Source Type: news

John Grisham book turns spotlight on futuristic cancer treatment
(Reuters) – A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer’s disease. “The Tumor” is a fictional account of a 35-year-old man with brain cancer who, a decade into the future, is treated with focused ultrasound – a real-life technology that is currently being researched as a potential cure for more than 50 diseases. Focused ultrasound uses soundwaves to destroy damaged tissue deep within the body, doing away with the need for incisions or radiation therapy. It ...
Source: Mass Device - March 14, 2016 Category: Medical Equipment Authors: MassDevice Tags: Oncology Focused Ultrasound Foundation Source Type: news

SuperSonic Imagine inks distro deal with Sandhill Scientific, releases 2015 earnings
SuperSonic Imagine said today it inked a U.S. distribution deal with Sandhill Scientific to distribute its Aixplorer ShearWave Elastography-equipped ultrasound system designed to assess liver disease, along with releasing its 2015 earnings. Through the agreement, Sandhill will have rights to sell the Aixplorer ultrasound system to gastroenterologists and hepatologists from March 14, while SuperSonic Imagine will keep its direct sales force targeted on radiology, breast and other clinical segments, the company said. Highlands Ranch, Colo.-based Sandhill Scientific develops and produces gastrointestinal diagnostic solutions...
Source: Mass Device - March 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Distribution Imaging SuperSonic Imagine S.A. Source Type: news

FDA OKs Xalkori (Crizotinib) for Rare Type of Advanced Lung Cancer
By Stacy SimonThe US Food and Drug Administration (FDA) has approved the first treatment for people with advanced, ROS1-positive non-small cell lung cancer. These tumors have a mutation in the ROS1 gene that affects only about 1% of people with non-small cell lung cancer. Many people with this type of lung cancer tend to be younger than the average lung cancer patient and are less likely to have been smokers.The drug, Xalkori (crizotinib), was previously approved for patients with advanced non-small cell lung cancer that has a mutation in a gene called ALK. It’s a targeted therapy that works by blocking the changes i...
Source: American Cancer Society :: News and Features - March 14, 2016 Category: Cancer & Oncology Tags: Lung Cancer - Non-Small Cell Source Type: news

Exalenz & ALF Study Group ink deal for BreathID acute liver failure study
This study is another important step in evaluating the advantages of BreathID as a non-invasive and accurate diagnostic and monitoring tool with lifesaving potential, in the broad field of liver disease,” Exalenz BioScience CEO Raffi Werner said in prepared remarks. Exalenz said the study is part of a growing series of investigational diagnostic aplication studies using the BreathID to diagnose serious liver conditions. The post Exalenz & ALF Study Group ink deal for BreathID acute liver failure study appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Clinical Trials Diagnostics Exalenz Biosciences Source Type: news

European Association of Urology (EAU) 2016 CongressEuropean Association of Urology (EAU) 2016 Congress
Read clinically focused news coverage of key developments from EAU 2016. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2016 Category: Cancer & Oncology Tags: Conference Coverage Source Type: news

Zambia: Kidney Disease in Children
[Times of Zambia] LAST week, I received this mail from Agnese Ruggiero, the World Kidney Day campaign coordinator who is based in Belgium. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 14, 2016 Category: African Health Source Type: news

Greater survival benefit shown in men with early and less aggressive mCRPC treated with Zytiga® plus prednisone
Janssen announced that data from a post-hoc analysis of the Phase III COU-AA-302 trial showed that ZYTIGA® plus prednisone provided an 11.8 months overall survival benefit, compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 14, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Patient care advanced prostate cancer COU-AA-302 trial European Association of Urology Latest News mCRPC Zytiga Source Type: news

Nigeria: Lautech Forum Raises Alarm Over Rising Kidney-Related Deaths
[Guardian] Prof. Olugbenga Ayodele, a renowned nephrologist, has called on Nigerians to take care of their health, especially their kidneys. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 14, 2016 Category: African Health Source Type: news

The European Association of Urology Upgrades UroLift(R) System Trial Data to its Highest Possible Classification - Level 1A - in its Guidelines
Further evidence from two multi-national randomized studies presented at EAU conference supports durability of UroLift® System treatment for men with enlarged prostate MUNICH, March 14, 2016 -- (Healthcare Sales & Marketing Network) -- The UroLift ... Devices, UrologyNeoTract, UroLift, Benign Prostatic Hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2016 Category: Pharmaceuticals Source Type: news

Study suggests gene may turn 'good' cholesterol into 'bad'
ConclusionThis study has built on previous observations that having very high levels of HDL – or "good" – cholesterol may not be as protective against heart and vascular disease as you'd assume. The study suggests that some people may have very high HDL cholesterol levels because they have an unusual variant of the SCARB1 gene, which normally codes for the receptor that picks up HDL cholesterol. The P376L variant of the gene was associated with the complete loss of function of this receptor. However, this study alone doesn't provide firm evidence of what effect this gene variant and high HDL cholesterol lev...
Source: NHS News Feed - March 14, 2016 Category: Consumer Health News Tags: Heart/lungs Genetics/stem cells Source Type: news

Role of Immune Cells in Hypertension and Renal InjuryRole of Immune Cells in Hypertension and Renal Injury
Find out more about the immune mechanisms involved in the development of salt-sensitive hypertension and renal disease. Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2016 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Missouri Cancer Associates and Urology Associates of Central Missouri to Participate in Boone Hospital Center’s Cancer Fair
Columbia, Missouri (March 14, 2016) ― Providers from Missouri Cancer Associates (MCA) and Urology Associates of Central Missouri (UACM), practices in The US Oncology Network, will be among the featured speakers providing information about cancer prevention and offering free cancer screenings at Boon... (Source: McKesson News)
Source: McKesson News - March 14, 2016 Category: Information Technology Source Type: news

Tenofovir Exposure and Kidney Function in Women With HIVTenofovir Exposure and Kidney Function in Women With HIV
This study examines the relationship between TFV exposure and subsequent kidney function in women living with HIV. AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 14, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Largest genomic study on kidney cancer brings hope for more effective treatments
(Baylor College of Medicine) What have historically been considered three major types of kidney cancer according to their histological characteristic, can be further distinguished into nine major subtypes through molecular analyses. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 14, 2016 Category: Cancer & Oncology Source Type: news

Brain-dead baby is kept on a ventilator so the child's kidneys can save an adult
Doctors from St James’s University Hospital in Leeds used a ventilator to keep the baby’s heart beating after it was declared brain dead to best preserve the 4cm kidneys for transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - March 13, 2016 Category: Consumer Health News Source Type: news

Study shows patients prefer iPads to doctors when discussing surgery
(European Association of Urology) Often patients undergo procedures without real informed consent being achieved due to technical language, jargon and time pressure, with up to half of patients finding it difficult to understand what their doctor tells them. Now a group of Australian doctors has prepared patients for surgery using iPads, and found that patients' understanding was much better than after a face-to-face consultation. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 13, 2016 Category: Global & Universal Source Type: news

Active surveillance for prostate cancer can give men good quality of life
(European Association of Urology) Choosing ongoing monitoring instead of immediate curative treatment (surgery or radiotherapy) leads to a better overall quality of life for men with low-risk prostate cancer. In fact, the quality of life (QoL) is about the same as for men who do not have cancer. These are the findings of a new long-term study comparing Active Surveillance, immediate curative treatment, and a reference group of men without cancer. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 13, 2016 Category: Global & Universal Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include the obesity paradox, early peanut feeding, incompatible kidney transplants, and ultra-processed food consumption (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 12, 2016 Category: Pediatrics Source Type: news

Core-Needle Biopsy Leads to 94% Accurate Renal Carcinoma Diagnosis
Adding core-needle biopsy to other clinical care may help improve outcomes for some patients with renal cell carcinoma...03/12/2016 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - March 12, 2016 Category: Urology & Nephrology Source Type: news

Severe Psoriasis Amplifies Immunoglobulin A Nephropathy RiskSevere Psoriasis Amplifies Immunoglobulin A Nephropathy Risk
Renal function should be monitored in patients with severe psoriasis because of the association between the disease and kidney complications, new research shows. Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 12, 2016 Category: Dermatology Tags: Dermatology News Source Type: news

RNA sequencing opens door to accurate, highly specific test for prostate cancer
(European Association of Urology) A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single test potentially opens the door for simple, accurate non-invasive testing for prostate cancer. This work is presented at the European Association of Urology Congress in Munich. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2016 Category: Global & Universal Source Type: news

Almost 1/3 of infertile men at increased risk of metabolic diseases as they age
(European Association of Urology) Men with fertility problems are at increased risk of metabolic diseases as they age, according to work being presented at the European Association of Urology conference in Munich. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 12, 2016 Category: Global & Universal Source Type: news

Study finds kidney transplant donation rates vary widely across Europe
(European Association of Urology) A new Europe-wide survey shows significant country-to-country differences in rates of kidney transplant donors. The survey shows for example within the EU, there is a x5 variation in the number of kidney donors per country (per head of population). This variation is probably due to different legal and social standards across Europe. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 12, 2016 Category: Global & Universal Source Type: news

Certain Biopsy Method Tied to Better Outcomes after Kidney Cancer (U.S. NewsandWorld Report)
A type of lab test called a "core-needle biopsy," performed on tissue taken from a mass on a kidney, may be better for certain kidney cancer patients, new research suggests. The study involved people with a renal (kidney) cell carcinoma-the most common type of kidney cancer in adults. Researchers led by Dr. Rosaleen Parsons, of Fox Chase Cancer Center in Philadelphia-one of the 26 NCCN Member Institutions, noted that incidence and death rates of the disease have climbed in recent de... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 12, 2016 Category: Cancer & Oncology Source Type: news

NeoTract launches MedLift trial
NeoTract said Monday it enrolled the 1st patient in its MedLift U.S. investigational device exemption trial of its UroLift system for treating patients with benign prostatic hyperplasia. The new study from Pleasanton, Calif.-based NeoTract will be conducted across 8 sites in the U.S. and will examine the safety and efficacy of the UroLift system for treating patients with BPH who have an obstructive median lobe, which the company says is currently contraindicated in the U.S. “Unlike other BPH procedures, the UroLift System directly opens the urethra without cutting, heating, or removing prostate tissue. In this way p...
Source: Mass Device - March 11, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Urology NeoTract Source Type: news

First Generic Version of Viagra Clears FDAFirst Generic Version of Viagra Clears FDA
Generic sildenafil citrate (Teva Pharmaceuticals) will be available in 25-, 50-, and 100-mg pills beginning in December 2017. FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 11, 2016 Category: Cardiology Tags: Urology News Alert Source Type: news

One Giant Leap for Mankind
With the president's $1 billion launch of the new National Cancer Moonshot, the promise we most desperately need to keep isn't found in the complexities of a trip to a distant planet: It's in the simplicity of the words spoken there. One giant leap for mankind. That's what we can - what we must - achieve this time in our now 45-year-old declared war against the killer that will claim not just some 600,000 Americans this year, but over 8 million people around the globe. Cancer accounts for one in every four deaths in the world. And lung cancer is by far the deadliest, with the U.S. Centers for Disease Control and Prevention...
Source: Healthy Living - The Huffington Post - March 11, 2016 Category: Consumer Health Advice Source Type: news

EndoBreak: Mismatched Kidney Transplants; Drinking Man's Diet
(MedPage Today) -- News and highlights from around the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 11, 2016 Category: Cardiology Source Type: news

Unilateral HIFU: More Cons Than Pros(tate)?Unilateral HIFU: More Cons Than Pros(tate)?
A small study of high-intensity focused ultrasound in localized prostate cancer fails to make the case for this treatment option, says Dr Gerald Chodak. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Assessment of depression prevalence and its relation with interleukin 18 one year after renal transplantation - Sahraei Z, Eshraghi A, Eslami N, Mehdizadeh M.
Renal transplantation is the treatment of choice for many patients with end-stage renal disease. Because there is little information about depression after kidney transplantation, we investigated frequency and determinant factors of depression and also its... (Source: SafetyLit)
Source: SafetyLit - March 11, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Eigen USA and Hitachi Medical Systems Europe Switzerland Announce a Collaborative Agreement for Hitachi to Distribute the Artemis, Eigen's Robotic 3D Targeted Prostate Biopsy Device
The combined Hitachi Noblus and Artemis Eigen systems will be showcased at the European Association of Urology annual meeting in Munich, March 12th-14th, 2016, Booth #E16 ZUG, Switzerland, March 11, 2016 -- (Healthcare Sales & Marketing Network) -- Eig... Devices, Oncology, DistributionHitachi Medical Systems, Artemis, Eigen, prostate biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 11, 2016 Category: Pharmaceuticals Source Type: news

Tanzania: KCMC Preparations to Establish Kidney Treatment Centre in Full Swing
[Citizen] Moshi -The Kilimanjaro Christian Medical Centre (KCMC) will start to treat kidney patients, it was revealed here yesterday by hospital director Dr Gilliard Masenga. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 11, 2016 Category: African Health Source Type: news

MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee(R), MedCom's Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy and Therapy Guidance, for use in Conjunction With Hitachi Ultrasound Systems
The combined Hitachi Noblus and MedCom BiopSee® systems will be showcased at the European Association of Urology (EAU) annual meeting in Munich, March 12th-14th, 2016, Booth #E16 ZUG, Switzerland, March 11, 2016 -- (Healthcare Sales & Marketing Netw... Devices, Radiology, Oncology, DistributionHitachi Medical Systems, MedCom GmbH, BiopSee, prostate biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 11, 2016 Category: Pharmaceuticals Source Type: news

Sofosbuvir and Simeprevir in the Post-transplant SettingSofosbuvir and Simeprevir in the Post-transplant Setting
What does the latest research tell us about the safety and efficacy of the antiviral drugs, sofosbuvir and simeprevir, for hepatitis C patients who have undergone liver transplants? BMJ Open Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Certain Biopsy Method Tied to Better Outcomes After Kidney Cancer
Title: Certain Biopsy Method Tied to Better Outcomes After Kidney CancerCategory: Health NewsCreated: 3/10/2016 12:00:00 AMLast Editorial Review: 3/11/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 11, 2016 Category: Cancer & Oncology Source Type: news

Blacks More Likely to Have Kidney Failure Than Whites: Study
Title: Blacks More Likely to Have Kidney Failure Than Whites: StudyCategory: Health NewsCreated: 3/10/2016 12:00:00 AMLast Editorial Review: 3/11/2016 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 11, 2016 Category: Nutrition Source Type: news

Severe Psoriasis Amplifies Immunoglobulin Nephropathy RiskSevere Psoriasis Amplifies Immunoglobulin Nephropathy Risk
Renal function should be monitored in patients with severe psoriasis because of the association between the disease and kidney complications, new research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2016 Category: Consumer Health News Tags: Dermatology News Source Type: news

SLU hepatologist awarded NIH grant to study liver, gut disorders
(Saint Louis University) Ajay Jain, M.D., a pediatric hepatologist and gastroenterologist, received a $703,620 grant from the National Institutes of Diabetes and Digestive and Kidney Diseases to continue studying strategies for PN-associated disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 11, 2016 Category: Global & Universal Source Type: news